DOWNREGULATION OF INFLAMMATORY MICRORNAS BY ILT3
It has been discovered that inhibition of two or more specific inflammatory miRs (30b, 21, 146a, and 155) suppresses T cell proliferation, promotes T cell anergy or induces the formation of suppressor T cells, thereby providing a focused therapy with minimal toxicity for disorders associated with ab...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | SUCIU-FOCA, NICOLE CHANG, CHIHAO HO, ERIC, KOONMING VLAD, GEORGE |
description | It has been discovered that inhibition of two or more specific inflammatory miRs (30b, 21, 146a, and 155) suppresses T cell proliferation, promotes T cell anergy or induces the formation of suppressor T cells, thereby providing a focused therapy with minimal toxicity for disorders associated with abnormally high immune responses. The corollary involves increasing the level of certain proinflammatory miRs thereby providing methods for immuno stimulation. It has also been discovered that significant increases of serum miR21 which occur in heart allograft rejection can be used to identify patients that have this disorder without requiring a biopsy.
On s'est aperçu que l'inhibition d'au moins deux miARN inflammatoires spécifiques (30b, 21, 146a et 155) inhibe la prolifération des lymphocytes T, renforce l'énergie des lymphocytes T ou induit la formation de lymphocytes T suppresseurs, ce qui assure un traitement ciblé, caractérisé par une toxicité minimale, contre les affections associées à une réponse immunitaire anormalement forte. Le corollaire implique une augmentation du niveau de certains miARN pro-inflammatoires, ce qui peut constituer le fondement de méthodes d'immunostimulation. On s'est également aperçu que des augmentations significatives des miARN21 sériques qui se produisent lors du rejet d'une allogreffe cardiaque peuvent être utilisées pour identifier les patients souffrant de cette affection sans qu'il soit nécessaire de procéder à une biopsie. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2013036282A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2013036282A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2013036282A23</originalsourceid><addsrcrecordid>eNrjZDBw8Q_3C3J1D_VxDPH091Pwd1Pw9HPzcfT1dQzxD4pU8PV0DvIP8nMMVnCKVPD0CTHmYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXx4f5GBobGBsZmRhZGjkbGxKkCAOKFJ14</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>DOWNREGULATION OF INFLAMMATORY MICRORNAS BY ILT3</title><source>esp@cenet</source><creator>SUCIU-FOCA, NICOLE ; CHANG, CHIHAO ; HO, ERIC, KOONMING ; VLAD, GEORGE</creator><creatorcontrib>SUCIU-FOCA, NICOLE ; CHANG, CHIHAO ; HO, ERIC, KOONMING ; VLAD, GEORGE</creatorcontrib><description>It has been discovered that inhibition of two or more specific inflammatory miRs (30b, 21, 146a, and 155) suppresses T cell proliferation, promotes T cell anergy or induces the formation of suppressor T cells, thereby providing a focused therapy with minimal toxicity for disorders associated with abnormally high immune responses. The corollary involves increasing the level of certain proinflammatory miRs thereby providing methods for immuno stimulation. It has also been discovered that significant increases of serum miR21 which occur in heart allograft rejection can be used to identify patients that have this disorder without requiring a biopsy.
On s'est aperçu que l'inhibition d'au moins deux miARN inflammatoires spécifiques (30b, 21, 146a et 155) inhibe la prolifération des lymphocytes T, renforce l'énergie des lymphocytes T ou induit la formation de lymphocytes T suppresseurs, ce qui assure un traitement ciblé, caractérisé par une toxicité minimale, contre les affections associées à une réponse immunitaire anormalement forte. Le corollaire implique une augmentation du niveau de certains miARN pro-inflammatoires, ce qui peut constituer le fondement de méthodes d'immunostimulation. On s'est également aperçu que des augmentations significatives des miARN21 sériques qui se produisent lors du rejet d'une allogreffe cardiaque peuvent être utilisées pour identifier les patients souffrant de cette affection sans qu'il soit nécessaire de procéder à une biopsie.</description><language>eng ; fre</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC ; GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPIRITS ; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS ; TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE ; TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINSTCLIMATE CHANGE ; VINEGAR ; WINE</subject><creationdate>2013</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130314&DB=EPODOC&CC=WO&NR=2013036282A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76418</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130314&DB=EPODOC&CC=WO&NR=2013036282A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SUCIU-FOCA, NICOLE</creatorcontrib><creatorcontrib>CHANG, CHIHAO</creatorcontrib><creatorcontrib>HO, ERIC, KOONMING</creatorcontrib><creatorcontrib>VLAD, GEORGE</creatorcontrib><title>DOWNREGULATION OF INFLAMMATORY MICRORNAS BY ILT3</title><description>It has been discovered that inhibition of two or more specific inflammatory miRs (30b, 21, 146a, and 155) suppresses T cell proliferation, promotes T cell anergy or induces the formation of suppressor T cells, thereby providing a focused therapy with minimal toxicity for disorders associated with abnormally high immune responses. The corollary involves increasing the level of certain proinflammatory miRs thereby providing methods for immuno stimulation. It has also been discovered that significant increases of serum miR21 which occur in heart allograft rejection can be used to identify patients that have this disorder without requiring a biopsy.
On s'est aperçu que l'inhibition d'au moins deux miARN inflammatoires spécifiques (30b, 21, 146a et 155) inhibe la prolifération des lymphocytes T, renforce l'énergie des lymphocytes T ou induit la formation de lymphocytes T suppresseurs, ce qui assure un traitement ciblé, caractérisé par une toxicité minimale, contre les affections associées à une réponse immunitaire anormalement forte. Le corollaire implique une augmentation du niveau de certains miARN pro-inflammatoires, ce qui peut constituer le fondement de méthodes d'immunostimulation. On s'est également aperçu que des augmentations significatives des miARN21 sériques qui se produisent lors du rejet d'une allogreffe cardiaque peuvent être utilisées pour identifier les patients souffrant de cette affection sans qu'il soit nécessaire de procéder à une biopsie.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC</subject><subject>GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPIRITS</subject><subject>TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS</subject><subject>TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE</subject><subject>TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINSTCLIMATE CHANGE</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2013</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDBw8Q_3C3J1D_VxDPH091Pwd1Pw9HPzcfT1dQzxD4pU8PV0DvIP8nMMVnCKVPD0CTHmYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXx4f5GBobGBsZmRhZGjkbGxKkCAOKFJ14</recordid><startdate>20130314</startdate><enddate>20130314</enddate><creator>SUCIU-FOCA, NICOLE</creator><creator>CHANG, CHIHAO</creator><creator>HO, ERIC, KOONMING</creator><creator>VLAD, GEORGE</creator><scope>EVB</scope></search><sort><creationdate>20130314</creationdate><title>DOWNREGULATION OF INFLAMMATORY MICRORNAS BY ILT3</title><author>SUCIU-FOCA, NICOLE ; CHANG, CHIHAO ; HO, ERIC, KOONMING ; VLAD, GEORGE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2013036282A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2013</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC</topic><topic>GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPIRITS</topic><topic>TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS</topic><topic>TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE</topic><topic>TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINSTCLIMATE CHANGE</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>SUCIU-FOCA, NICOLE</creatorcontrib><creatorcontrib>CHANG, CHIHAO</creatorcontrib><creatorcontrib>HO, ERIC, KOONMING</creatorcontrib><creatorcontrib>VLAD, GEORGE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SUCIU-FOCA, NICOLE</au><au>CHANG, CHIHAO</au><au>HO, ERIC, KOONMING</au><au>VLAD, GEORGE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>DOWNREGULATION OF INFLAMMATORY MICRORNAS BY ILT3</title><date>2013-03-14</date><risdate>2013</risdate><abstract>It has been discovered that inhibition of two or more specific inflammatory miRs (30b, 21, 146a, and 155) suppresses T cell proliferation, promotes T cell anergy or induces the formation of suppressor T cells, thereby providing a focused therapy with minimal toxicity for disorders associated with abnormally high immune responses. The corollary involves increasing the level of certain proinflammatory miRs thereby providing methods for immuno stimulation. It has also been discovered that significant increases of serum miR21 which occur in heart allograft rejection can be used to identify patients that have this disorder without requiring a biopsy.
On s'est aperçu que l'inhibition d'au moins deux miARN inflammatoires spécifiques (30b, 21, 146a et 155) inhibe la prolifération des lymphocytes T, renforce l'énergie des lymphocytes T ou induit la formation de lymphocytes T suppresseurs, ce qui assure un traitement ciblé, caractérisé par une toxicité minimale, contre les affections associées à une réponse immunitaire anormalement forte. Le corollaire implique une augmentation du niveau de certains miARN pro-inflammatoires, ce qui peut constituer le fondement de méthodes d'immunostimulation. On s'est également aperçu que des augmentations significatives des miARN21 sériques qui se produisent lors du rejet d'une allogreffe cardiaque peuvent être utilisées pour identifier les patients souffrant de cette affection sans qu'il soit nécessaire de procéder à une biopsie.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; fre |
recordid | cdi_epo_espacenet_WO2013036282A2 |
source | esp@cenet |
subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINSTCLIMATE CHANGE VINEGAR WINE |
title | DOWNREGULATION OF INFLAMMATORY MICRORNAS BY ILT3 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T22%3A19%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SUCIU-FOCA,%20NICOLE&rft.date=2013-03-14&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2013036282A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |